OpenSAFELY Vaccine Coverage Report
AstraZeneca / Priority Group 4
Data from combined, up to 2021-03-20.
| Vaccinated at 2021-03-20 (%) | Vaccinated at 2021-03-20 (n) | Population | Vaccinated at 2021-03-13 (%) | Vaccinated in past week (%) | ||
|---|---|---|---|---|---|---|
| Overall | - | 55.6% | 2,604,868 | 4,688,159 | 54.9% | 0.7% |
| Sex | Female | 55.0% | 1,386,721 | 2,522,296 | 54.2% | 0.8% |
| Male | 56.2% | 1,218,147 | 2,165,863 | 55.6% | 0.6% | |
| Ethnicity | White - British | 58.9% | 1,507,471 | 2,560,943 | 58.4% | 0.4% |
| White - Irish | 52.3% | 14,707 | 28,105 | 51.8% | 0.5% | |
| White - Any other White background | 42.7% | 62,328 | 146,013 | 41.8% | 0.9% | |
| Mixed - White and Black Caribbean | 38.1% | 4,501 | 11,816 | 36.4% | 1.7% | |
| Mixed - White and Black African | 39.1% | 4,746 | 12,152 | 37.2% | 1.9% | |
| Mixed - White and Asian | 46.0% | 3,514 | 7,637 | 44.4% | 1.6% | |
| Mixed - Any other mixed background | 41.4% | 6,391 | 15,435 | 40.0% | 1.4% | |
| Asian or Asian British - Indian | 49.2% | 59,976 | 121,863 | 47.8% | 1.4% | |
| Asian or Asian British - Pakistani | 43.7% | 42,728 | 97,825 | 40.9% | 2.7% | |
| Asian or Asian British - Bangladeshi | 52.9% | 26,250 | 49,637 | 49.7% | 3.2% | |
| Asian or Asian British - Any other Asian background | 45.3% | 29,211 | 64,449 | 43.7% | 1.7% | |
| Black or Black British - Caribbean | 35.7% | 15,309 | 42,861 | 33.9% | 1.8% | |
| Black or Black British - African | 37.4% | 38,787 | 103,824 | 35.0% | 2.4% | |
| Black or Black British - Any other Black background | 35.2% | 6,636 | 18,858 | 33.1% | 2.0% | |
| Other ethnic groups - Chinese | 46.0% | 6,412 | 13,944 | 44.9% | 1.1% | |
| Other ethnic groups - Any other ethnic group | 41.3% | 16,156 | 39,130 | 39.9% | 1.4% | |
| Patients with any other ethnicity code | 56.4% | 350,007 | 620,886 | 55.8% | 0.6% | |
| Ethnicity not stated | 56.1% | 15,974 | 28,469 | 55.4% | 0.7% | |
| Ethnicity not recorded | 55.9% | 393,645 | 704,235 | 55.4% | 0.5% | |
| Ethnicity (broad categories) | White | 57.9% | 1,584,520 | 2,735,089 | 57.5% | 0.5% |
| Mixed | 40.7% | 19,166 | 47,054 | 39.1% | 1.6% | |
| South Asian | 47.4% | 158,179 | 333,781 | 45.3% | 2.1% | |
| Black | 36.7% | 60,746 | 165,550 | 34.5% | 2.2% | |
| Other | 42.5% | 22,582 | 53,074 | 41.2% | 1.4% | |
| Unknown | 56.1% | 759,640 | 1,353,590 | 55.6% | 0.6% | |
| Index of Multiple Deprivation | 1 (most deprived) | 50.9% | 503,468 | 989,009 | 49.6% | 1.3% |
| 2 | 53.3% | 503,839 | 945,434 | 52.4% | 0.9% | |
| 3 | 56.6% | 527,807 | 932,799 | 56.1% | 0.5% | |
| 4 | 58.1% | 524,097 | 901,880 | 57.7% | 0.4% | |
| 5 (least deprived) | 59.6% | 521,969 | 876,400 | 59.3% | 0.3% | |
| Unknown | 55.5% | 23,653 | 42,623 | 55.1% | 0.4% | |
| Clinical Risk Groups | Patients in Any Clinical Risk Group | 54.7% | 1,645,889 | 3,007,214 | 53.8% | 0.9% |
| Patients with Immunosuppression | 54.4% | 235,991 | 434,154 | 53.8% | 0.6% | |
| Patients with CKD | 57.8% | 237,944 | 411,642 | 57.4% | 0.4% | |
| Patients who have Chronic Respiratory Disease | 58.0% | 341,845 | 589,015 | 57.6% | 0.5% | |
| Patients with Diabetes | 51.8% | 708,155 | 1,366,274 | 50.4% | 1.5% | |
| Patients with Chronic Liver disease | 55.2% | 116,921 | 211,974 | 54.3% | 0.9% | |
| Patients with CNS Disease (including Stroke/TIA) | 58.1% | 239,638 | 412,664 | 57.5% | 0.6% | |
| Patients with Chronic heart disease | 58.5% | 547,652 | 936,194 | 58.0% | 0.5% | |
| Patients with Asplenia or Dysfunction of the Spleen | 51.5% | 42,672 | 82,824 | 51.0% | 0.5% | |
| Patients with Wider Learning Disability | 54.5% | 30,625 | 56,182 | 53.2% | 1.3% | |
| Patients with Severe Mental Health | 52.6% | 41,111 | 78,127 | 51.0% | 1.7% | |
| Other Groups | Patients who are shielding (High Risk from COVID-19) | 51.2% | 1,168,552 | 2,280,565 | 50.0% | 1.2% |
| Patients with Morbid Obesity | 53.5% | 178,353 | 333,473 | 52.2% | 1.3% | |
| Patients who are pregnant | 23.5% | 6,664 | 28,350 | 21.4% | 2.1% |